Repligen Corporation
Repligen Corporation develops bioprocessing technologies and systems for biological drug manufacturing. They offer Protein A ligands, cell culture growth factors, chromatography products, ELISA test kits, and filtration products. Their chromatography products include OPUS columns and CaptivA resins. The company also provides process analytics products under the SoloVPE, FlowVPE, and FlowVPX brands. Products are sold to life sciences, biopharmaceutical, and diagnostics companies, laboratory researchers, and contract manufacturers.
Overview
Sector
Medical Instruments & Supplies
Strengths
- Consistent growth: revenue has compounded at 15.0% a year over 5 years, rising in 4 of them.
- Improving fundamentals over the last year: return on assets up 2.6 points, gross margin up 9.0 points and asset turnover up 11.6%.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 4.2%) has been below its cost of capital of 8.2% in each of the last 6 years.
- Our discounted cash flow target price (22.95 USD) is 86% below the current price.
- Unstable profitability: operating margin ranged from -5% to 26% over the last 6 years, with operating losses in 1 of them.
- Valued at a premium to its Medical Instruments & Supplies peers: EV/EBITDA 68.7x vs. a median of 16.0x.
- Earnings are projected to decline (-5.5% per year).
Key Financial Data